Vimarsana
Biggest News Aggregation in the World

Page 33 - Us Communications News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Us Communications. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Us Communications Today - Breaking & Trending Today

Hikma marks two-year anniversary of KLOXXADO® launch by surpassing 375,000 doses donated in the US - Vimarsana News

Hikma marks two-year anniversary of KLOXXADO® launch by surpassing 375,000 doses donated in the US

/PRNewswire/ -- Hikma Pharmaceuticals PLC (Hikma), the multinational pharmaceutical company, announces that on the two-year anniversary of its launch, it has...

GALDERMA AND NATIONAL BREAST CANCER FOUNDATION HONOR BREAST CANCER SURVIVORS AND THEIR BIGGEST CHAMPIONS IN THE "FACING BREAST CANCER TOGETHER" CAMPAIGN - Vimarsana News

GALDERMA AND NATIONAL BREAST CANCER FOUNDATION HONOR BREAST CANCER SURVIVORS AND THEIR BIGGEST CHAMPIONS IN THE "FACING BREAST CANCER TOGETHER" CAMPAIGN

/PRNewswire/ -- Galderma, the emerging pure-play dermatology category leader, today announced a new campaign to provide education and support for breast cancer...

DHL Express Introduces Sustainable Solution for its U.S. Aviation Operations - Vimarsana News

DHL Express Introduces Sustainable Solution for its U.S. Aviation Operations

/PRNewswire/ -- DHL Express, the world's leading provider of international express shipping services, today unveiled its first, innovative mobile charging cart...

Ipsen : announces withdrawal of palovarotene NDA, confirming intention to re-submit following additional data analyses -Today at 09:36 am - Vimarsana News

Ipsen : announces withdrawal of palovarotene NDA, confirming intention to re-submit following additional data analyses -Today at 09:36 am

This follows ongoing dialogue with the U.S. FDA regarding the palovarotene NDA review, initiated in May 2021 Paris , Friday 13 August, 2021 - Ipsen today...

Hikma Ventures invests in Octave Bioscience, a precision care platform for Multiple Sclerosis and other neurodegenerative diseases - Vimarsana News

Hikma Ventures invests in Octave Bioscience, a precision care platform for Multiple Sclerosis and other neurodegenerative diseases

/PRNewswire/ -- Hikma Pharmaceuticals PLC (Hikma), the multinational pharmaceutical company, announces that its venture capital arm, Hikma Ventures, has...